SSA
HELP

Schonfeld Strategic Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Schonfeld Strategic Advisors’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,737
Closed -$1.65M – 2216
2021
Q3 		$1.65M Buy
+19,737
New +$1.73M 0.02% 784

Other funds holding HELP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PCC
Perry Creek Capital New York $218M AUM 18.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
CCG
Ceeto Capital Group Coral Gables, Florida $369M AUM 34.8% 1-Year Est. Return
T
TCWP Beachwood, Ohio $40.8M AUM 31.25% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Schonfeld Strategic Advisors's HELP Position: Q4 2021 in Review

Schonfeld Strategic Advisors sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2021, closing a stake of 19,737 shares — an estimated $1.65M sold.

Schonfeld Strategic Advisors first reported a position in HELP in Q3 2021 and held it in 1 quarter. The position peaked at $1.65M in Q3 2021. 65 funds tracked by Wall St. Rank hold HELP as of Q4 2021.

  • Schonfeld Strategic Advisors reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 19,737 Helus Pharma Inc. Common Stock shares in Q4 2021, an estimated $1.65M.
  • Schonfeld Strategic Advisors first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Helus Pharma Inc. Common Stock position peaked at $1.65M in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.